Telmisartan: a Different Angiotensin II Receptor Blocker Protecting a Different Population?

Author： Burnier M  

Publisher： Field House Publishing

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.37, Iss.6, 2009-11, pp. : 1662-1679

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Candesartan: widening indications for this angiotensin II receptor blocker?

By Mendis B   Page SR  

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 12, 2009-08 ,pp. : 1995-2007

Informa Healthcare

Access to resources Recommend Favorite

Telmisartan, an Angiotensin II Type 1 Receptor Blocker, Inhibits Advanced Glycation End-product (AGE)-elicited Hepatic Insulin Resistance via Peroxisome Proliferator-activated Receptor-γ Activation

By Yoshida T   Yamagishi S   Matsui T   Nakamura K   Ueno T   Takeuchi M   Sata M  

The Journal of International Medical Research, Vol. 36, Iss. 2, 2008-03 ,pp. : 237-243

Field House Publishing

Access to resources Recommend Favorite

The Telmisartan Renoprotective Study from Incipient Nephropathy to Overt Nephropathy – Rationale, Study Design, Treatment Plan and Baseline Characteristics of the Incipient to Overt: Angiotensin II Receptor Blocker, Telmisartan, Investigation on Type 2 Diabetic Nephropathy (INNOVATION) Study

By Makino H   Haneda M   Babazono T   Moriya T   Ito S   Iwamoto Y   Kawamori R   Takeuchi M   Katayama S  

The Journal of International Medical Research, Vol. 33, Iss. 6, 2005-11 ,pp. : 677-686

Field House Publishing

Access to resources Recommend Favorite

Telmisartan, an Angiotensin II Type 1 Receptor Blocker, Inhibits Advanced Glycation End-product (AGE)-induced Monocyte Chemoattractant Protein-1 Expression in Mesangial Cells Through Downregulation of Receptor for AGEs via Peroxisome Proliferator-activated Receptor-γ Activation

By Matsui T   Yamagishi S   Ueda S   Nakamura K   Imaizumi T   Takeuchi M   Inoue H  

The Journal of International Medical Research, Vol. 35, Iss. 4, 2007-07 ,pp. : 482-489

Field House Publishing

Access to resources Recommend Favorite

Antiproteinuric Effect of Angiotensin-converting Enzyme Inhibitors and an Angiotensin II Receptor Blocker in Patients with Lupus Nephritis

By Kitamura N   Matsukawa Y   Takei M   Sawada S  

The Journal of International Medical Research, Vol. 37, Iss. 3, 2009-05 ,pp. : 892-898

Field House Publishing

Access to resources Recommend Favorite